Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2012 from OUS - National Advisory Unit on Late Effects after Cancer Treatment

25 publications found

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S et al. (2012)
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Ann Oncol, 24 (4), 878-88
DOI 10.1093/annonc/mds579, PubMed 23152360

Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G (2012)
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer
J Clin Oncol, 30 (32), 4004-10
DOI 10.1200/JCO.2011.40.8914, PubMed 23071246

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Cvancarova M, Aagnes B, Fosså SD, Lambert PC, Møller B, Bray F (2012)
Proportion cured models applied to 23 cancer sites in Norway
Int J Cancer, 132 (7), 1700-10
DOI 10.1002/ijc.27802, PubMed 22927104

Dahl AA, Olssøn I (2012)
Unfavorable health conditions associated with high social anxiety in the elderly: a community-based study
Nord J Psychiatry, 67 (1), 30-7
DOI 10.3109/08039488.2012.668935, PubMed 22429103

Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L (2012)
Contemporary management of postchemotherapy testis cancer
Eur Urol, 62 (5), 867-76
DOI 10.1016/j.eururo.2012.08.014, PubMed 22938868

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
DOI 10.1038/bmt.2012.63, PubMed 22522568

Fung C, Fossa SD, Beard CJ, Travis LB (2012)
Second malignant neoplasms in testicular cancer survivors
J Natl Compr Canc Netw, 10 (4), 545-56
DOI 10.6004/jnccn.2012.0052, PubMed 22491051

Grytli HH, Fagerland MW, Fosså SD, Taskén KA, Håheim LL (2012)
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
Prostate, 73 (3), 250-60
DOI 10.1002/pros.22564, PubMed 22821802

Hauglann B, Benth JŠ, Fosså SD, Dahl AA (2012)
A cohort study of permanently reduced work ability in breast cancer patients
J Cancer Surviv, 6 (3), 345-56
DOI 10.1007/s11764-012-0215-0, PubMed 22457217

Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M, Oldenburg J, Dahl AA, Bremnes RM, Fosså SD (2012)
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
J Clin Oncol, 30 (30), 3752-63
DOI 10.1200/JCO.2012.43.4431, PubMed 23008318

Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Ostenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M (2012)
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Ann Oncol, 24 (5), 1385-92
DOI 10.1093/annonc/mds621, PubMed 23247661

Kristiansen W, Aschim EL, Andersen JM, Witczak O, Fosså SD, Haugen TB (2012)
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men
Int J Androl, 35 (6), 819-27
DOI 10.1111/j.1365-2605.2012.01297.x, PubMed 22882535

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD (2012)
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer
BJU Int, 111 (2), 221-32
DOI 10.1111/j.1464-410X.2012.11198.x, PubMed 22672151

Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R (2012)
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
Eur J Cancer, 48 (16), 2993-3000
DOI 10.1016/j.ejca.2012.05.014, PubMed 22677260

Michelsen TM, Dørum A, Cvancarova M, Liavaag AH, Dahl AA (2012)
Association between hysterectomy with ovarian preservation and cardiovascular disease in a Norwegian population-based sample
Gynecol Obstet Invest, 75 (1), 61-7
DOI 10.1159/000345072, PubMed 23220872

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F et al. (2012)
Risk of treatment-related esophageal cancer among breast cancer survivors
Ann Oncol, 23 (12), 3081-3091
DOI 10.1093/annonc/mds144, PubMed 22745217

Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fosså A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F (2012)
Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
PLoS One, 7 (11), e49705
DOI 10.1371/journal.pone.0049705, PubMed 23185413

Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
Patient knowledge of late effects of acute lymphoblastic leukaemia
Tidsskr Nor Laegeforen, 132 (18), 2052-5
DOI 10.4045/tidsskr.12.0153, PubMed 23038194

Sorensen T, Dahl AA, Fossa SD, Holmen J, Lien L, Danbolt LJ (2012)
Is 'Seeking God's Help' Associated with Life Satisfaction and Disease-specific Quality of Life in Cancer Patients? The HUNT Study
Arch. Psychol. Relig., 34 (2), 191-213
DOI 10.1163/15736121-12341237

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD (2012)
A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design
BMC Cancer, 12, 123
DOI 10.1186/1471-2407-12-123, PubMed 22458865

Torp S, Nielsen RA, Fosså SD, Gudbergsson SB, Dahl AA (2012)
Change in employment status of 5-year cancer survivors
Eur J Public Health, 23 (1), 116-22
DOI 10.1093/eurpub/ckr192, PubMed 22227027

Torp S, Nielsen RA, Gudbergsson SB, Fosså SD, Dahl AA (2012)
Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study
J Cancer Surviv, 6 (3), 315-23
DOI 10.1007/s11764-012-0228-8, PubMed 22706884

0.11s